Cardlytics Inc (NASDAQ:CDLX) Director Sells $1,050,058.24 in Stock

Cardlytics Inc (NASDAQ:CDLX) Director Tony Weisman sold 33,484 shares of the firm’s stock in a transaction that occurred on Monday, August 12th. The shares were sold at an average price of $31.36, for a total transaction of $1,050,058.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Shares of NASDAQ:CDLX opened at $33.26 on Friday. The company has a quick ratio of 2.37, a current ratio of 2.37 and a debt-to-equity ratio of 0.99. Cardlytics Inc has a 52-week low of $9.80 and a 52-week high of $34.30. The company has a 50 day moving average of $28.87 and a two-hundred day moving average of $21.26. The company has a market capitalization of $750.68 million, a price-to-earnings ratio of -15.54 and a beta of 1.76.

Cardlytics (NASDAQ:CDLX) last issued its quarterly earnings data on Thursday, August 8th. The company reported ($0.12) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.35) by $0.23. Cardlytics had a negative net margin of 19.60% and a negative return on equity of 64.83%. The company had revenue of $48.73 million during the quarter, compared to the consensus estimate of $43.77 million. During the same quarter last year, the company earned ($0.21) earnings per share. Cardlytics’s revenue for the quarter was up 37.0% on a year-over-year basis. On average, equities analysts anticipate that Cardlytics Inc will post -1.08 earnings per share for the current year.

A number of large investors have recently modified their holdings of the business. Gamco Investors INC. ET AL grew its position in Cardlytics by 2.6% in the second quarter. Gamco Investors INC. ET AL now owns 15,850 shares of the company’s stock valued at $412,000 after acquiring an additional 400 shares in the last quarter. Bank of Montreal Can grew its position in Cardlytics by 16,371.4% in the second quarter. Bank of Montreal Can now owns 1,153 shares of the company’s stock valued at $30,000 after acquiring an additional 1,146 shares in the last quarter. SG Americas Securities LLC grew its position in shares of Cardlytics by 2.3% during the first quarter. SG Americas Securities LLC now owns 61,277 shares of the company’s stock worth $1,014,000 after buying an additional 1,402 shares in the last quarter. BlackRock Inc. grew its position in shares of Cardlytics by 0.4% during the fourth quarter. BlackRock Inc. now owns 422,718 shares of the company’s stock worth $4,578,000 after buying an additional 1,610 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. acquired a new stake in shares of Cardlytics during the second quarter worth approximately $60,000. 70.43% of the stock is owned by institutional investors.

Several research analysts recently commented on CDLX shares. KeyCorp raised their price target on shares of Cardlytics from $25.00 to $26.00 and gave the company an “overweight” rating in a report on Friday, May 10th. Raymond James raised their price target on shares of Cardlytics from $24.00 to $40.00 and gave the company an “outperform” rating in a report on Friday, August 9th. ValuEngine lowered shares of Cardlytics from a “strong-buy” rating to a “buy” rating in a report on Tuesday, April 23rd. Zacks Investment Research lowered shares of Cardlytics from a “buy” rating to a “hold” rating in a report on Tuesday, July 23rd. Finally, Bank of America reaffirmed a “buy” rating and issued a $32.00 price objective (up previously from $22.00) on shares of Cardlytics in a research report on Wednesday, July 24th. One research analyst has rated the stock with a hold rating and eight have issued a buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $33.29.

About Cardlytics

Cardlytics, Inc operates a purchase intelligence platform in the United States and the United Kingdom. It operates in two segments, Cardlytics Direct and Other Platform Solutions. The company's platform is the Cardlytics Direct solution, a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels.

Featured Story: Derivative

Insider Buying and Selling by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.